Literature DB >> 17727929

Which role for pre-treatment laparoscopic staging?

Anna Fagotti1, Francesco Fanfani, Romina Longo, Francesco Legge, Alessandra Mari, Maria L Gagliardi, Giovanni Scambia.   

Abstract

OBJECTIVE: To investigate in cervical cancer patients the impact of pre-treatment laparoscopic staging on treatment plan and disease free survival.
METHODS: A review of the present literature has been performed and data have been compared to results obtained in a large series of patients not surgically staged.
RESULTS: Among 134 abstracts resulting from Medline research, 13 were deemed potentially relevant to the study questions. The presence of intraperitoneal diffusion of disease can be recognized in locally advanced cervical cancer patients (LACC) in a percentage ranging between 1.9% and 29%. The rate of aortic positive nodes in clinically negative LACC patients cases has been reported between 11% and 25%, by laparoscopy. In our Division, 152 LACC patients have been treated between October 1997 and February 2007. None of the patients has been submitted to pre-treatment laparoscopic staging, whereas in all cases a pre-operative MRI has been performed. With a median follow-up 28.0 months (range 3-126 months), 31 recurrences have been observed. The 5-year DFS has been 83% and OS 90%. Although only a retrospective analysis can be carried out, such result well compares to cases surgically staged.
CONCLUSIONS: Pre-treatment surgical staging can identify positive nodes in LACC patients considered clinically negative, and recognize intraperitoneal disease, thus making the physician tailor the treatment on the bases of histopathological result. Moreover, it offers the potential advantage of debulking of macroscopically positive nodes, and to transpose the ovary outside the radiation. However, the positive impact on DFS has still to be demonstrated.

Entities:  

Mesh:

Year:  2007        PMID: 17727929     DOI: 10.1016/j.ygyno.2007.07.005

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  5 in total

1.  Survival benefit of laparoscopic surgical staging-guided radiation therapy in locally advanced cervical cancer.

Authors:  Dae Gy Hong; Nae Yoon Park; Gun Oh Chong; Young Lae Cho; Il Soo Park; Yoon Soon Lee
Journal:  J Gynecol Oncol       Date:  2010-09-28       Impact factor: 4.401

2.  Patterns of care in patients with cervical cancer 2012: results of a survey among German radiotherapy departments and out-patient health care centers.

Authors:  S Marnitz; C Köhler; A Rauer; A Schneider; V Budach; A Tsunoda; M Mangler
Journal:  Strahlenther Onkol       Date:  2013-07-27       Impact factor: 3.621

3.  Extended field chemoradiation for cervical cancer patients with histologically proven para-aortic lymph node metastases after laparaoscopic lymphadenectomy.

Authors:  Simone Marnitz; Johanna Schram; Volker Budach; Irina Sackerer; Giuseppe Filiberto Vercellino; Jalid Sehouli; Christhardt Köhler
Journal:  Strahlenther Onkol       Date:  2014-11-21       Impact factor: 3.621

4.  Aspects of Therapy for Cervical Cancer in Germany 2012 - Results from a Survey of German Gynaecological Hospitals.

Authors:  M Mangler; N Zech; A Schneider; C Köhler; S Marnitz
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-03       Impact factor: 2.915

5.  Experiences of pretreatment laparoscopic surgical staging in patients with locally advanced cervical cancer: results of a prospective study.

Authors:  Myong Cheol Lim; Jaeman Bae; Jeong-Yoel Park; Soyi Lim; Sokbom Kang; Sang-Soo Seo; Joo-Yong Kim; Ju-Won Rho; Sang-Yoon Park
Journal:  J Gynecol Oncol       Date:  2008-06-20       Impact factor: 4.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.